Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Zealand Extracts is a biotechnology company specializing in the development and manufacture of high-performance bioactive ingredients derived from New Zealand's unique flora, specifically Sauvignon Blanc grape seeds and skins. Utilizing a proprietary 100% aqueous extraction process, the company produces the Vinanza range of antioxidants, which are clinically proven to support skin health, cardiovascular function, and digestive wellness. The company's sustainable approach avoids harsh chemicals, ensuring the bioactivity and purity of its extracts for use in the global nutraceutical and cosmeceutical industries. In 2022, the company was acquired by Indena, a global leader in botanical active principles, to expand its portfolio of natural health solutions. The company continues to operate from its base in Marlborough, leveraging local agricultural resources to provide scientifically validated natural ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Zealand Extracts.